These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 24042126)
1. The effect of ABCB1 C3435T polymorphism on pharmacokinetics of tacrolimus in liver transplantation: a meta-analysis. Liu YY; Li C; Cui Z; Fu X; Zhang S; Fan LL; Ma J; Li G Gene; 2013 Dec; 531(2):476-88. PubMed ID: 24042126 [TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the effect of MDR1 C3435 polymorphism on tacrolimus pharmacokinetics in renal transplant recipients. Li Y; Hu X; Cai B; Chen J; Bai Y; Tang J; Liao Y; Wang L Transpl Immunol; 2012 Aug; 27(1):12-8. PubMed ID: 22504573 [TBL] [Abstract][Full Text] [Related]
3. Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients. Wei-lin W; Jing J; Shu-sen Z; Li-hua W; Ting-bo L; Song-feng Y; Sheng Y Liver Transpl; 2006 May; 12(5):775-80. PubMed ID: 16628701 [TBL] [Abstract][Full Text] [Related]
4. The effect of MDR1 (ABCB1) polymorphism on the pharmacokinetic of tacrolimus in Turkish renal transplant recipients. Akbas SH; Bilgen T; Keser I; Tuncer M; Yucetin L; Tosun O; Gultekin M; Luleci G Transplant Proc; 2006 Jun; 38(5):1290-2. PubMed ID: 16797284 [TBL] [Abstract][Full Text] [Related]
5. Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients. Tada H; Tsuchiya N; Satoh S; Kagaya H; Li Z; Sato K; Miura M; Suzuki T; Kato T; Habuchi T Transplant Proc; 2005 May; 37(4):1730-2. PubMed ID: 15919447 [TBL] [Abstract][Full Text] [Related]
6. Tacrolimus dosing in Chinese renal transplant patients is related to MDR1 gene C3435T polymorphisms. Li D; Gui R; Li J; Huang Z; Nie X Transplant Proc; 2006 Nov; 38(9):2850-2. PubMed ID: 17112846 [TBL] [Abstract][Full Text] [Related]
7. The effect of Shao S; Hu L; Han Z; Hou K; Fang H; Zhang G; Feng Y; Huang L Transl Androl Urol; 2020 Apr; 9(2):673-683. PubMed ID: 32420174 [TBL] [Abstract][Full Text] [Related]
8. Effect of the ABCB1 3435C>T polymorphism on tacrolimus concentrations and dosage requirements in liver transplant recipients. Bonhomme-Faivre L; Picard V; Saliba F; Abbara C; Fodil M; Chaunoy M; Farinotti R Am J Health Syst Pharm; 2009 Sep; 66(18):1645-51. PubMed ID: 19729569 [TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimus. Vafadari R; Bouamar R; Hesselink DA; Kraaijeveld R; van Schaik RH; Weimar W; Baan CC; van Gelder T Ther Drug Monit; 2013 Aug; 35(4):459-65. PubMed ID: 23743668 [TBL] [Abstract][Full Text] [Related]
11. CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation. Glowacki F; Lionet A; Buob D; Labalette M; Allorge D; Provôt F; Hazzan M; Noël C; Broly F; Cauffiez C Nephrol Dial Transplant; 2011 Sep; 26(9):3046-50. PubMed ID: 21677300 [TBL] [Abstract][Full Text] [Related]
12. Effect of MDR1 polymorphisms on the blood concentrations of tacrolimus in Turkish renal transplant patients. Ciftci HS; Ayna TK; Caliskan YK; Guney I; Bakkaloglu H; Nane I; Aydin AE; Turkmen A; Gurtekin M Transplant Proc; 2013 Apr; 45(3):895-900. PubMed ID: 23622581 [TBL] [Abstract][Full Text] [Related]
13. Effect of ABCB1 3435C>T Genetic Polymorphism on Pharmacokinetic Variables of Tacrolimus in Adult Renal Transplant Recipients: A Systematic Review and Meta-analysis. Peng W; Lin Y; Zhang H; Meng K Clin Ther; 2020 Oct; 42(10):2049-2065. PubMed ID: 32888708 [TBL] [Abstract][Full Text] [Related]
14. Single-nucleotide polymorphism C3435T in the ABCB1 gene is associated with opioid consumption in postoperative pain. Candiotti K; Yang Z; Xue L; Zhang Y; Rodriguez Y; Wang L; Hao S; Gitlin M Pain Med; 2013 Dec; 14(12):1977-84. PubMed ID: 24034787 [TBL] [Abstract][Full Text] [Related]
15. Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation. Zhang X; Liu ZH; Zheng JM; Chen ZH; Tang Z; Chen JS; Li LS Clin Transplant; 2005 Oct; 19(5):638-43. PubMed ID: 16146556 [TBL] [Abstract][Full Text] [Related]
16. Do drug transporter (ABCB1) SNPs influence cyclosporine and tacrolimus dose requirements and renal allograft outcome in the posttransplantation period? Singh R; Srivastava A; Kapoor R; Mittal RD J Clin Pharmacol; 2011 Apr; 51(4):603-15. PubMed ID: 20571034 [TBL] [Abstract][Full Text] [Related]
17. ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysis. Kim IW; Yun HY; Choi B; Han N; Park SY; Lee ES; Oh JM Clin Ther; 2012 Aug; 34(8):1816-26. PubMed ID: 22796246 [TBL] [Abstract][Full Text] [Related]
18. Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients. Quteineh L; Verstuyft C; Furlan V; Durrbach A; Letierce A; Ferlicot S; Taburet AM; Charpentier B; Becquemont L Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):546-52. PubMed ID: 19067682 [TBL] [Abstract][Full Text] [Related]
19. The Impact of ABCB1 SNPs on Tacrolimus Pharmacokinetics in Liver or Kidney Transplant Recipients: A Meta-analysis. Li Z; Wang X; Li D; Cheng S; Dong Y; Yang H; Li X Curr Pharm Des; 2023; 29(29):2323-2335. PubMed ID: 37817654 [TBL] [Abstract][Full Text] [Related]
20. Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients. Loh PT; Lou HX; Zhao Y; Chin YM; Vathsala A Transplant Proc; 2008 Jun; 40(5):1690-5. PubMed ID: 18589174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]